You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 19, 2024

CLINICAL TRIALS PROFILE FOR FUSILEV

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for fusilev

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01789723 ↗	Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn	Withdrawn	Acrotech Biopharma LLC	Phase 1	2013-03-01	The purpose of this study is determine the optimal dose and schedule of Fusilev to prevent or reduce Mucositis in patients with Non-Hodgkin's Lymphoma receiving Folotyn treatment.
NCT01789723 ↗	Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn	Withdrawn	Spectrum Pharmaceuticals, Inc	Phase 1	2013-03-01	The purpose of this study is determine the optimal dose and schedule of Fusilev to prevent or reduce Mucositis in patients with Non-Hodgkin's Lymphoma receiving Folotyn treatment.
NCT01820091 ↗	Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®	Withdrawn	Acrotech Biopharma LLC	Phase 1	2013-04-01	To determine the optimal dose and schedule of Fusilev to prevent or reduce Folotyn-related Grade 3 or higher oral mucositis in patients with Non-Small Cell Lung Cancer.
NCT01820091 ↗	Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®	Withdrawn	Spectrum Pharmaceuticals, Inc	Phase 1	2013-04-01	To determine the optimal dose and schedule of Fusilev to prevent or reduce Folotyn-related Grade 3 or higher oral mucositis in patients with Non-Small Cell Lung Cancer.
NCT03222089 ↗	Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC	Withdrawn	Fujian Cancer Hospital	Phase 2	2017-07-20	A randomized phase II trial of FOLFOXIRI in Combination With GM-CSF and IL-2 (FOLFOXIGIL) Versus FOLFOXIRI as First-line Treatment for Patients With Metastatic Colorectal Cancer.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for fusilev

Condition Name

Chart
Table

Condition Name for fusilev
Intervention	Trials
Stage IVA Colorectal Cancer AJCC v7	2
Stage IVB Colorectal Cancer AJCC v7	2
Stage IV Colorectal Cancer AJCC v7	2
Stage IV Pancreatic Cancer AJCC v6 and v7	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for fusilev
Intervention	Trials
Colorectal Neoplasms	3
Adenocarcinoma	2
Mucositis	2
Pancreatic Neoplasms	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for fusilev

Trials by Country

Map
Table

Trials by Country for fusilev
Location	Trials
United States	5
China	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for fusilev
Location	Trials
Utah	1
Minnesota	1
Georgia	1
Arizona	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for fusilev

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for fusilev
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	1
Phase 1/Phase 2	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for fusilev
Clinical Trial Phase	Trials
Withdrawn	3
Recruiting	1
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for fusilev

Sponsor Name

Chart
Table

Sponsor Name for fusilev
Sponsor	Trials
Spectrum Pharmaceuticals, Inc	2
National Cancer Institute (NCI)	2
Acrotech Biopharma LLC	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for fusilev
Sponsor	Trials
Industry	5
Other	3
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.